P279: Application of next-generation sequencing in the diagnosis of inherited metabolic disorders in Iran: An 11-year overview

The most common test ordered in individuals with diagnosis after 2 tests was exome (N=12), with diagnosis after 3 tests was Noonan/RASopathy panel (N=12), with diagnosis after 4 tests was exome (N=1).The individual who was diagnosed after 9 tests was diagnosed by a cardiac panel.This individual never had a Noonan/RASopathy panel or exome ordered, however symptoms were non-specific including developmental delays and mitral valve prolapse. Conclusion:The majority of individuals in this cohort did have a molecular diagnosis confirmed which demonstrates the remarkable advance in the molecular understanding of RASopathies.The most commonly ordered test was Noonan/RASopathy panel.Exome testing was the second most common test leading to diagnosis with utilization increasing over time.Of note, exome had a higher diagnostic yield than Noonan/RASopathy panel.This could be due to ongoing discovery of new genes in the RASopathy pathway and the ability of exome to incorporate candidate genes and non-specific clinical indications whereas a panel is curated and updates may be delayed.Exome should be considered an alternative first-tier testing to a Noonan/RASopathy panel when there is suspicion for a RASopathy diagnosis in order to improve diagnostic yield and timely diagnosis.

Authors

Institutions

Publication Details

Journal
Genetics in Medicine Open
Published
2025-01-01
DOI
https://doi.org/10.1016/j.gimo.2025.102244
Primary Topic
Metabolism and Genetic Disorders
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

P279: Application of next-generation sequencing in the diagnosis of inherited metabolic disorders in Iran: An 11-year overview

Mahsa Tahmasebivand, Bahram Haghi Ashtiani, Kimia Kahrizi, Parishad Saei et al.
Genetics in Medicine Open
Metabolism and Genetic Disorders
article

P279: Application of next-generation sequencing in the diagnosis of inherited metabolic disorders in Iran: An 11-year overview

Mahsa Tahmasebivand, Bahram Haghi Ashtiani, Kimia Kahrizi, Parishad Saei, Fatemeh Fatehi, Ariana Kariminejad, Mina Makvand, Hilda Yazdan, Zohreh Elahi, Saeed Talebi, Mahsa Fadaee, Fatemeh Ahangari, Shahriar Nafissi, Mahmoud Reza Ashrafi, Amir Ahmadpour, Mehri Ashki, Parvaneh Karimzadeh, Farzad Fatehi, Haleh Habibi, Ali Asghar Okhovat, Banafsheh Salmani, Babak Zamani, Maryam Beheshtian, Shima Dehdahsi, Fariba Afroozan, Raheleh Vazehan, Hossein Najmabadi, Farhad Mahvelati Shamsabadi, Abbas Ghaderi, Zohreh Vahidi, Afshin Fayyazi, Elham Parsimehr, Khadijeh Noudehi, Shima Zamanian Najafabadi, Payam Sarraf, Mahdieh Kooshki, Maryam Mozaffarpour Nouri, Negar Molaei, Parnian Alagha, Elmira Shiuokhi
article en

Abstract

The most common test ordered in individuals with diagnosis after 2 tests was exome (N=12), with diagnosis after 3 tests was Noonan/RASopathy panel (N=12), with diagnosis after 4 tests was exome (N=1).The individual who was diagnosed after 9 tests was diagnosed by a cardiac panel.This individual never had a Noonan/RASopathy panel or exome ordered, however symptoms were non-specific including developmental delays and mitral valve prolapse. Conclusion:The majority of individuals in this cohort did have a molecular diagnosis confirmed which demonstrates the remarkable advance in the molecular understanding of RASopathies.The most commonly ordered test was Noonan/RASopathy panel.Exome testing was the second most common test leading to diagnosis with utilization increasing over time.Of note, exome had a higher diagnostic yield than Noonan/RASopathy panel.This could be due to ongoing discovery of new genes in the RASopathy pathway and the ability of exome to incorporate candidate genes and non-specific clinical indications whereas a panel is curated and updates may be delayed.Exome should be considered an alternative first-tier testing to a Noonan/RASopathy panel when there is suspicion for a RASopathy diagnosis in order to improve diagnostic yield and timely diagnosis.

Genetics in Medicine OpenVol. 3
Hamedan University of Medical Sciences (IR), Iran University of Medical Sciences (IR), Imam Khomeini Hospital (IR), Firoozgar General Hospital (IR), Isfahan Fertility and Infertility Center (IR), Children's Medical Center (IR), University of Social Welfare and Rehabilitation Sciences (IR), Shahid Beheshti University of Medical Sciences (IR), Tehran University of Medical Sciences (IR)
Zero hunger
Openalex Percentile: Top 93%
Metabolism and Genetic Disorders
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.